4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $90.00K in the quarter ending September 30, 2025, with 2,900.00% growth. This brings the company's revenue in the last twelve months to $120.00K, up 605.88% year-over-year. In the year 2024, 4D Molecular Therapeutics had annual revenue of $37.00K, down -99.82%.

• Revenue (ttm): $120.00K
• Revenue Growth: +605.88%
• P/S Ratio: 3,856.62
• Revenue / Employee: $529
• Employees: 227
• Market Cap: 462.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.00K	-20.69M	-99.82%
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%
Dec 31, 2019	6.99M	-7.14M	-50.56%
Dec 31, 2018	14.13M	8.34M	144.04%
Dec 31, 2017	5.79M	-	-